UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.14B
AUM Growth
-$1.26B
Cap. Flow
-$1.81B
Cap. Flow %
-19.82%
Top 10 Hldgs %
41.43%
Holding
1,256
New
311
Increased
521
Reduced
82
Closed
288
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Top Buys

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$680M
2
CTXS
Citrix Systems Inc
CTXS
+$434M
3
ROG icon
Rogers Corp
ROG
+$386M
4
ATVI
Activision Blizzard
ATVI
+$344M
5
MIME
Mimecast Limited
MIME
+$253M

Top Sells

Rank Stock Value
1
INFO icon
IHS Markit Ltd. Common Shares
INFO
+$1.62B
2
NUAN
Nuance Communications, Inc.
NUAN
+$1.61B
3
XLNX
Xilinx Inc
XLNX
+$638M
4
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$465M
5
CONE
CyrusOne Inc Common Stock
CONE
+$464M

Sector Composition

Rank Sector Weight
1 Technology 30.21%
2 Financials 21.65%
3 Healthcare 15.19%
4 Industrials 8.94%
5 Miscellaneous 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NVNO icon
726
enVVeno Medical
NVNO
$5.14M
$494K 0.01%
+2,215
New +$430K
2022 Q1
0 quarters
JLL icon
727
Jones Lang LaSalle
JLL
$13.6B
$455K 0.01%
+1,900
New +$463K
2022 Q1
0 quarters
RAIN icon
728
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$448K ﹤0.01%
+88,270
New +$708K
2022 Q1
0 quarters
HR icon
729
DELISTED
Healthcare Realty Trust Incorporated
HR
$440K ﹤0.01%
+16,000
New +$472K
2022 Q1
0 quarters
WTI icon
730
PUT
W&T Offshore
WTI
$551M
$429K ﹤0.01%
1,580,400
+127,300
+9% +$561K
2021 Q2
3 quarters
RCL icon
731
PUT
Royal Caribbean
RCL
$73.4B
$425K ﹤0.01%
36,700
+6,400
+21% +$504K
2021 Q2
3 quarters
FUBO icon
732
PUT
FuboTV Inc
FUBO
$249M
$398K ﹤0.01%
5,000
+833
+20% +$97.2K
2021 Q4
1 quarter
NCLH icon
733
PUT
Norwegian Cruise Line
NCLH
$6.83B
$392K ﹤0.01%
69,200
+10,100
+17% +$206K
2021 Q2
3 quarters
VRDN icon
734
Viridian Therapeutics
VRDN
$2.08B
$370K ﹤0.01%
+20,000
New +$384K
2022 Q1
0 quarters
M icon
735
PUT
Macy's
M
$5.92B
$363K ﹤0.01%
164,500
+27,000
+20% +$692K
2021 Q2
3 quarters
HOG icon
736
PUT
Harley-Davidson
HOG
$2.81B
$357K ﹤0.01%
148,800
-109,800
-42% -$4.23M
2020 Q1
8 quarters
XME icon
737
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.96B
$351K ﹤0.01%
+270,000
New +$13.8M
2022 Q1
0 quarters
NKTR icon
738
Nektar Therapeutics
NKTR
$1.26B
$334K ﹤0.01%
+4,133
New +$612K
2022 Q1
0 quarters
FSLY icon
739
PUT
Fastly Inc
FSLY
$3.98B
$316K ﹤0.01%
+60,000
New +$1.4M
2022 Q1
0 quarters
EVLVW icon
740
DELISTED
Evolv Technologies Warrant
EVLVW
$292K ﹤0.01%
787,485
+13,900
+2% +$6.83K
2021 Q3
2 quarters
LUMN icon
741
PUT
Lumen Technologies, Inc. Common Stock
LUMN
$4.69B
$287K ﹤0.01%
128,000
– –
2021 Q2
3 quarters
NHICW
742
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$275K ﹤0.01%
892,115
+25,865
+3% +$10.5K
2021 Q4
1 quarter
RDFN icon
743
PUT
DELISTED
Redfin
RDFN
$267K ﹤0.01%
+60,000
New +$1.55M
2022 Q1
0 quarters
PRPB.WS
744
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$253K ﹤0.01%
+257,513
New +$262K
2022 Q1
0 quarters
RVNC icon
745
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
$250K ﹤0.01%
+100,000
New +$1.52M
2022 Q1
0 quarters
IMPX.WS
746
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$250K ﹤0.01%
308,870
+5,464
+2% +$4.44K
2021 Q1
4 quarters
AKICW
747
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$249K ﹤0.01%
226,639
+4,010
+2% +$3.91K
2021 Q1
4 quarters
WYNN icon
748
PUT
Wynn Resorts
WYNN
$7.59B
$245K ﹤0.01%
7,000
+1,700
+32% +$143K
2021 Q3
2 quarters
IPOF.WS
749
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$241K ﹤0.01%
196,131
+3,470
+2% +$4.64K
2021 Q1
4 quarters
NAVI icon
750
PUT
Navient
NAVI
$868M
$232K ﹤0.01%
107,800
-120,200
-53% -$2.21M
2021 Q2
3 quarters
28 29
30
31 32

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2022 Portfolio in Review

As of Q1 2022, UBS O'Connor held 1,256 positions worth $9.14B, down 12% from $10.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.81B in Q1 2022, closing 288 positions and reducing 82 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $1.62B position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Citrix Systems Inc worth $433M.

  • UBS O'Connor's largest Q1 2022 buy was Citrix Systems Inc: 4,293,687 shares worth $433M.
  • UBS O'Connor added most to Cerner Corp in Q1 2022, an estimated $680M increase.
  • UBS O'Connor's biggest Q1 2022 reduction was EQT Corp, cutting an estimated $81.9M.
  • UBS O'Connor fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $1.62B.
  • UBS O'Connor's ten largest holdings make up 41% of its $9.14B portfolio in Q1 2022.
  • UBS O'Connor opened 311 new positions and closed 288 in Q1 2022.
  • UBS O'Connor's portfolio value fell 12% quarter-over-quarter to $9.14B.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.